Literature DB >> 32053479

Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China.

Zhanwei Du, Lin Wang, Simon Cauchemez, Xiaoke Xu, Xianwen Wang, Benjamin J Cowling, Lauren Ancel Meyers.   

Abstract

On January 23, 2020, China quarantined Wuhan to contain coronavirus disease (COVID-19). We estimated the probability of transportation of COVID-19 from Wuhan to 369 other cities in China before the quarantine. Expected COVID-19 risk is >50% in 130 (95% CI 89-190) cities and >99% in the 4 largest metropolitan areas.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; China; SARS-CoV-2; Wuhan; coronavirus; epidemiology; importation; outbreak; severe acute respiratory syndrome coronavirus 2; viruses

Mesh:

Year:  2020        PMID: 32053479      PMCID: PMC7181905          DOI: 10.3201/eid2605.200146

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In December 2019, a novel coronavirus, since named severe acute respiratory syndrome coronavirus 2, emerged in Wuhan, China (), causing a respiratory illness that the World Health Organization has named coronavirus disease (COVID-19). On January 30, 2020, the World Health Organization declared the outbreak a public health emergency of international concern (). By January 31, 2020, a total of 192 fatalities and 3,215 laboratory-confirmed cases had been reported in Wuhan; 8,576 additional cases were spread across >300 cities in mainland China, and 127 exported cases were reported in 23 countries spanning Asia, Europe, Oceania, and North America. The rapid global expansion, rising fatalities, unknown animal reservoir, and evidence of person-to-person transmission potential (,) initially resembled the 2003 SARS epidemic and raised concerns about global spread. On January 22, 2020, China announced a travel quarantine of Wuhan and by January 30 expanded the radius to include 16 cities, encompassing a population of 45 million. At the time of the quarantine, China was already 2 weeks into the 40-day Spring Festival, during which residents and visitors make several billion trips throughout China to celebrate the Lunar New Year (). Considering the timing of exported COVID-2019 cases reported outside of China, we estimate that only 8.95% (95% credibility interval [CrI] 2.22%–28.72%) of persons infected in Wuhan by January 12 might have had COVID-19 confirmed by January 22. By limiting our estimate to infections occurring ≥10 days before the quarantine, we account for an ≈5–6-day incubation period and 4–5 days between symptom onset and case detection (Appendix) (–,). The low detection rate coupled with an average lag of 10 days between infection and detection () suggest that newly infected persons who traveled out of Wuhan just before the quarantine might have remained infectious and undetected in dozens of cities in China for days to weeks. Moreover, these silent importations already might have seeded sustained outbreaks that were not immediately apparent. We estimated the probability of transportation of infectious COVID-19 cases from Wuhan to cities throughout China before January 23 by using a simple model of exponential growth coupled with a stochastic model of human mobility among 369 cities in China (Appendix). Given that ≈98% of all trips taken during this period were made by train or car, our analysis of air, rail, and road travel data yields more granular risk estimates than possible with air passenger data alone (). By fitting our epidemiologic model to data on the first 19 cases reported outside of China, we estimate an epidemic doubling time of 7.31 days (95% CrI 6.26–9.66 days) and a cumulative total of 12,400 (95% CrI 3,112–58,465) infections in Wuhan by January 22 (Appendix). Both estimates are consistent with a similar epidemiologic analysis of the first 425 cases confirmed in Wuhan (). Assuming these rates of early epidemic growth, we estimate that 130 cities in China have a >50% chance of having a COVID-19 case imported from Wuhan in the 3 weeks preceding the quarantine (Figure). By January 26, a total of 107 of these 130 high-risk cities had reported cases. However, 23 had not, including 5 cities with importation probabilities >99% and populations >2 million: Bazhong, Fushun, Laibin, Ziyang, and Chuxiong.
Figure

Risks for transportation of coronavirus disease (COVID-19) from Wuhan, China, before a quarantine was imposed on January 23, 2020. A) Daily travel volume to and from Wuhan, given as a percentage of the Wuhan population. Gray shading indicates the start of Spring Festival season on January 10, 2020, a peak travel period in China. B) Estimated and reported daily prevalence of COVID-19 in Wuhan. The green line and shading indicate model estimates of cumulative cases since December 1, 2019, with 95% credible interval bounds, assuming an epidemic doubling time of 7.31 days (95% credible interval 6.26–9.66 days). Black dots indicate cumulative confirmed case counts during January 1–22, 2020 (). Gray shading at right indicates the start of Spring Festival season. C) Probability that >1 COVID-19 case infected in Wuhan traveled to cities in China by January 22, 2020. The 131 cities with a risk threshold >50% are indicated in shades of orange; 239 cities below that threshold are indicated in shades of blue. Map generated by using Mapbox (https://www.mapbox.com).

Risks for transportation of coronavirus disease (COVID-19) from Wuhan, China, before a quarantine was imposed on January 23, 2020. A) Daily travel volume to and from Wuhan, given as a percentage of the Wuhan population. Gray shading indicates the start of Spring Festival season on January 10, 2020, a peak travel period in China. B) Estimated and reported daily prevalence of COVID-19 in Wuhan. The green line and shading indicate model estimates of cumulative cases since December 1, 2019, with 95% credible interval bounds, assuming an epidemic doubling time of 7.31 days (95% credible interval 6.26–9.66 days). Black dots indicate cumulative confirmed case counts during January 1–22, 2020 (). Gray shading at right indicates the start of Spring Festival season. C) Probability that >1 COVID-19 case infected in Wuhan traveled to cities in China by January 22, 2020. The 131 cities with a risk threshold >50% are indicated in shades of orange; 239 cities below that threshold are indicated in shades of blue. Map generated by using Mapbox (https://www.mapbox.com). Under our lower bound estimate of 6.26 days for the doubling time, 190/369 cities lie above the 50% threshold for importation. Our risk assessment identified several cities throughout China likely to be harboring yet undetected cases of COVID-19 a week after the quarantine, suggesting that early 2020 ground and rail travel seeded cases far beyond the Wuhan region under quarantine. Our conclusions are based on several key assumptions. To design our mobility model, we used data from Tencent (https://heat.qq.com), a major social media company that hosts applications including WeChat (≈1.13 billion active users in 2019) and QQ (≈808 million active users in 2019) (Statista, https://www.statista.com); consequently, our model might be demographically biased by the Tencent user base. Further, considerable uncertainty regarding the lag between infection and case detection remains. Our assumption of a 10-day lag is based on early estimates for the incubation period of COVID-19 () and prior estimates of the lag between symptom onset and detection for SARS (). We expect that estimates for the doubling time and incidence of COVID-19 will improve as reconstructed linelists and more granular epidemiologic data become available (Appendix). However, our key qualitative insights likely are robust to these uncertainties, including extensive prequarantine exportations throughout China and far greater case counts in Wuhan than those reported before the quarantine.

Appendix

Additional information on risk for transportation of 2019 novel coronavirus from Wuhan to other cities in China.
  4 in total

1.  War stories.

Authors:  Martin Enserink
Journal:  Science       Date:  2013-03-15       Impact factor: 47.728

2.  Asymptomatic SARS coronavirus infection among healthcare workers, Singapore.

Authors:  Annelies Wilder-Smith; Monica D Teleman; Bee H Heng; Arul Earnest; Ai E Ling; Yee S Leo
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

  4 in total
  125 in total

1.  Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2.

Authors:  Samuel Clifford; Carl A B Pearson; Petra Klepac; Kevin Van Zandvoort; Billy J Quilty; Rosalind M Eggo; Stefan Flasche
Journal:  J Travel Med       Date:  2020-08-20       Impact factor: 8.490

Review 2.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

Review 3.  Coronavirus Disease 2019-COVID-19.

Authors:  Kuldeep Dhama; Sharun Khan; Ruchi Tiwari; Shubhankar Sircar; Sudipta Bhat; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales
Journal:  Clin Microbiol Rev       Date:  2020-06-24       Impact factor: 26.132

Review 4.  Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths.

Authors:  Shivraj Padiyar; Debashish Danda
Journal:  Eur J Rheumatol       Date:  2020-10-08

5.  SARS-CoV-2 diagnosis: a single-centre experience.

Authors:  Ion Maruntelu; Andreea Mirela Caragea; Maria Tizu; Ileana Constantinescu
Journal:  J Med Life       Date:  2021 Mar-Apr

6.  COVID-19 infection data encode a dynamic reproduction number in response to policy decisions with secondary wave implications.

Authors:  Michael A Rowland; Todd M Swannack; Michael L Mayo; Matthew Parno; Matthew Farthing; Ian Dettwiller; Glover George; William England; Molly Reif; Jeffrey Cegan; Benjamin Trump; Igor Linkov; Brandon Lafferty; Todd Bridges
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.996

7.  Clinical Characteristics of Foreign-Imported COVID-19 Cases in Xi'an, China.

Authors:  Li Zhang; Minjie Liu; Jianying Li; Xiaoli Li; Li Cheng; Yahong Ji; Na Li; Junning Wang
Journal:  Int J Gen Med       Date:  2021-05-25

8.  Evaluation of Patients with Suspicion of COVID-19 in Pediatric Emergency Department.

Authors:  Emel Eksi Alp; Nazan Dalgic; Vuslat Yilmaz; Yuksel Altuntas; Haci Mustafa Ozdemir
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02

9.  Impact of the COVID-19 pandemic on stress, resilience and depression in health professionals: a cross-sectional study.

Authors:  Isabel Manzanares; Sonia Sevilla Guerra; María Lombraña Mencía; Nihan Acar-Denizli; Josep Miranda Salmerón; Gemma Martinez Estalella
Journal:  Int Nurs Rev       Date:  2021-06-07       Impact factor: 3.384

Review 10.  Diagnosis of COVID-19 in symptomatic patients: An updated review.

Authors:  M N Zahan; H Habibi; A Pencil; J Abdul-Ghafar; S A Ahmadi; N S Juyena; M T Rahman; M S Parvej
Journal:  Vacunas       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.